Guilford (GLFD) - Steadily Rising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Czechsinthemail who wrote (96)	9/14/1997 10:42:00 PM
From: NeuroInvestment	of 496

Two comments: 1) It is true that some profit-taking is to be expected given the runup. But when looking at sales by management, it should be kept in mind that during the Blech fiasco, when no reasonable financing was available, GLFD management kicked in their own funds to keep the company going. One cannot blame them for diversifying a bit. 2)The nearterm key event to watch for will be whether RPR picks up their option on the Taxol polymer delivery vehicle program, and at what terms. If they do not, GLFD can shop it around as of October 1. Given the RPR oncology focus, it would be surprising if they did not. NeuroInvestment

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next